Home Genzyme

Genzyme

acquired
-
Biotechnology R&D Developer
Basic
Enterprise Profile

Basic Information

Genzyme Corporation is a biotechnology company. The company's portfolio of products and services focuses on rare genetic disorders, renal diseases, orthopedics, oncology, transplant, and immunological diseases. Genzyme’s operations are divided into four segments: Genetic Diseases, Cardiometabolic and Renal, Biosurgery, and Hematology Oncology.
Genzyme Corporation
Cambridge,Massachusetts,United States of America
more than 500 people
January 01, 1981
--

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Biotechnology
Concept
Orthopedics Tumor Immune System Diseases Rare Diseases Therapeutic Products
Application Scenarios
Innovative Drugs Small Nucleic Acid Drugs